TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial.

Evanthia Galanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.